IP Library Granted Patent US 8,366,657
Granted Patent B2
US 8,366,657 · App. 12/839,956 · Granted Feb 5, 2013

Needleless injection device components, systems, and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,366,657
App. No.
12/839,956
Granted
Feb 5, 2013
Kind
B2
Abstract

A high-pressure fluid injection system, which includes a rechargeable injection chamber with a proximal end, a distal end, and an internal opening extending from the proximal end to the distal end, a plunger slideably engaged with the internal opening of the injection chamber, an injection tube extending from the distal end of the injection chamber and in fluidic communication with the internal opening of the injection chamber, and a check valve between the proximal and distal ends of the injection chamber. The internal opening includes a high-pressure zone adjacent to the check valve and having a first diameter, and a low-pressure zone proximal to the high-pressure zone and having a second diameter that is larger than the first diameter.

Claims (24)

1. A high-pressure fluid injection system for targeted delivery of fluid to a treatment site within a patient, the injection system comprising:

a rechargeable injection chamber comprising a proximal end, a distal end, and an internal opening extending from the proximal end to the distal end;

a plunger slideably engaged with the internal opening of the injection chamber;

a first sealing member and a second sealing member, both of which are operatively engaged with the plunger, wherein a distance that the first sealing member is positioned from a distal end of the plunger is smaller than a distance that the second sealing member is spaced from the distal end of the plunger;

an injection tube extending from the distal end of the injection chamber and in fluidic communication with the internal opening of the injection chamber; and

a check valve between the proximal and distal ends of the injection chamber,

wherein the internal opening comprises a first zone adjacent to the check valve and having a first diameter, and a second zone proximal to the first zone and having a second diameter that is larger than the first diameter, and wherein the first sealing member is spaced from an inner wall surface of the second zone when the first and second sealing members are positioned in the second zone.

2. The fluid injection system of claim 1 , further comprising a reservoir in fluidic communication with the second zone of the injection chamber.

3. The fluid injection system of claim 1 , wherein the second sealing member is in contact with the inner wall surface of the second zone when the first and second sealing members are positioned in the second zone.

4. The fluid injection system of claim 1 , wherein the first sealing member is engageable with an inner wall of the first zone when the second sealing member is engaged with the inner wall of the second zone.

5. The fluid injection system of claim 1 , wherein the plunger is slideable in a distal direction to cause engagement of the first sealing member and the first zone.

6. The fluid injection system of claim 5 , wherein advancement of the first sealing member into the first zone opens the check valve.

7. A method of injecting fluid, comprising the steps of:

providing a high-pressure fluid injection system comprising:

a rechargeable injection chamber comprising a proximal end, a distal end, and an internal opening extending from the proximal end to the distal end;

a plunger slideably engaged with the internal opening of the injection chamber;

first and second sealing members operatively engaged with the plunger, both of which are operatively engaged with the plunger, wherein the first sealing member is positioned closer to a distal end of the plunger than the second sealing member;

a tube extending from the distal end of the injection chamber and in fluidic communication with the internal opening of the injection chamber; and

a check valve between the proximal and distal ends of the injection chamber,

wherein the internal opening comprises a first zone adjacent to the check valve and having a first diameter and a second zone proximal to the first zone and having a second diameter that is larger than the first diameter, wherein the first zone comprises a higher pressure area than the second zone, and wherein the first sealing member is spaced from an inner wall surface of the second zone when the first and second sealing members are positioned in the second zone; and

advancing the plunger in a distal direction until a first sealing member engages with the first zone and the check valve opens.

8. The method of claim 7 , further comprising stopping the advancement of the plunger to allow the check valve to close.

9. The method of claim 8 , further comprising retracting the plunger in an opposite direction from the plunger advancement to create a vacuum in the first zone, thereby disengaging the first sealing member from the first zone.

10. The method of claim 7 , wherein the second sealing member is in contact with the inner wall surface of the second zone when the first and second sealing members are positioned in the second zone.

Assignments (14)
RELEASE OF SECURITY INTEREST Recorded Apr 26, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH HOLDINGS, LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO GENERIC HOLDINGS, INC. (FORMERLY KNOWN AS PAR PHARMACEUTICALS COMPANIES, INC.); ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0795 →
RELEASE OF SECURITY INTEREST Recorded Apr 25, 2024
From: WILMINGTON TRUST, NATIONAL ASSOCIATION
To: ACTIENT PHARMACEUTICALS LLC; ASTORA WOMEN’S HEALTH LLC; AUXILIUM PHARMACEUTICALS, LLC; AUXILIUM US HOLDINGS, LLC; BIOSPECIFICS TECHNOLOGIES CORP.; BIOSPECIFICS TECHNOLOGIES LLC; DAVA INTERNATIONAL, LLC; DAVA PHARMACEUTICALS, LLC; ENDO PHARMACEUTICALS INC.; ENDO PHARMACEUTICALS SOLUTIONS INC. (FORMERLY KNOWN AS INDEVUS PHARMACEUTICALS, INC.); GENERICS BIDCO I, LLC; GENERICS INTERNATIONAL (US), INC.; PAR PHARMACEUTICAL, INC.; PAR PHARMACEUTICAL COMPANIES, INC.; PAR STERILE PRODUCTS, LLC (FORMERLY KNOWN AS JHP PHARMACEUTICALS, LLC); QUARTZ SPECIALTY PHARMACEUTICALS, LLC; SLATE PHARMACEUTICALS, LLC; VINTAGE PHARMACEUTICALS, LLC
Reel/Frame 067239/0542 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055846/0246 →
CONFIRMATORY GRANT OF SECURITY INTEREST IN UNITED STATES PATENTS Recorded Apr 6, 2021
From: BIOSPECIFICS TECHNOLOGIES LLC; PAR PHARMACEUTICAL, INC.; AUXILIUM US HOLDINGS, LLC; ASTORA WOMEN'S HEALTH, LLC; ENDO PHARMACEUTICALS SOLUTIONS INC.; ENDO PHARMACEUTICALS, INC.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION
Reel/Frame 055845/0618 →
RELEASE OF SECURITY INTEREST Recorded Apr 28, 2017
From: DEUTSCHE BANK AG NEW YORK BRANCH
To: ENDO PHARMACEUTICALS, INC.; ENDO PHARMACEUTICALS SOLUTIONS, INC.; ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042362/0001 →
CHANGE OF NAME Recorded Apr 21, 2017
From: ASTORA WOMEN'S HEALTH, INC.
To: ASTORA WOMEN'S HEALTH HOLDINGS, LLC
Reel/Frame 042310/0682 →
CHANGE OF NAME Recorded Apr 21, 2017
From: AMS RESEARCH CORPORATION
To: AMS RESEARCH, LLC
Reel/Frame 042310/0335 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2017
From: AMS RESEARCH, LLC
To: AMERICAN MEDICAL SYSTEMS, LLC
Reel/Frame 042092/0417 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 21, 2017
From: AMERICAN MEDICAL SYSTEMS, LLC
To: AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
Reel/Frame 042092/0559 →
CHANGE OF NAME Recorded Apr 21, 2017
From: AMERICAN MEDICAL SYSTEMS HOLDINGS, INC.
To: ASTORA WOMEN'S HEALTH, INC.
Reel/Frame 042310/0640 →
GRANT OF SECURITY INTEREST IN PATENTS Recorded Mar 20, 2014
From: ENDO PHARMACEUTICALS SOLUTIONS, INC.; ENDO PHARMACEUTICALS, INC.; AMS RESEARCH CORPORATION; AMERICAN MEDICAL SYSTEMS, INC.; LASERSCOPE
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 032491/0440 →
RELEASE OF PATENT SECURITY INTEREST Recorded Mar 3, 2014
From: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
To: AMS RESEARCH CORPORATION
Reel/Frame 032380/0053 →
SECURITY AGREEMENT Recorded Jul 22, 2011
From: AMS RESEARCH CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 026632/0535 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 17, 2010
From: CRANK, JUSTIN M
To: AMS RESEARCH CORPORATION
Reel/Frame 025002/0930 →